Breaking News Instant updates and real-time market news.

FLOW

SPX Flow

$25.91 /

+0.84 (+3.35%)

11:02
03/30/20
03/30
11:02
03/30/20
11:02

SPX Flow upgraded to Buy at Seaport Global as P&E deal gets done

As previously reported, Seaport Global analyst Walt Liptack upgraded SPX Flow to Buy from Neutral with a $33 price target. The analyst notes that the company's 2020 outlook included the divestiture of the Power & Energy business. However, he believes that investors had doubts about the deal getting completed due to the coronavirus and oil price shock crisis, which reduced the P&E EBITDA outlook. Liptack thinks SPX Flow's announcement that the company completed the sale of the P&E business with net proceeds of about $400M, should be a catalyst for the stock. Further, he believes that SPX Flow is positioned to come out of the coronavirus recession with higher operating leverage and cash flow.

FLOW SPX Flow
$25.91 /

+0.84 (+3.35%)

03/30/20 Seaport Global
SPX Flow upgraded to Buy from Neutral at Seaport Global
02/11/20 Vertical Research
SPX Flow upgraded to Hold from Sell at Vertical Research
01/08/20 Vertical Research
SPX Flow downgraded to Sell from Hold at Vertical Research
11/04/19 Buckingham
SPX FLOW price target raised to $53 from $45 at Buckingham

TODAY'S FREE FLY STORIES

Periodicals
Latam Airlines U.S. bankruptcy filing to delay bailout until July, Reuters says » 07:28
05/29/20
05/29
07:28
05/29/20
07:28
LTM

Latam Airlines

$1.12 /

-0.13 (-10.44%)

, AZUL

Azul

$8.14 /

-0.26 (-3.10%)

, GOL

Gol Linhas

$4.50 /

-0.2 (-4.26%)

Latam Airlines'…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

AZUL Azul
$8.14 /

-0.26 (-3.10%)

GOL Gol Linhas
$4.50 /

-0.2 (-4.26%)

LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

05/28/20 BofA
Latam Airlines reinstated with an Underperform at BofA
05/27/20 Deutsche Bank
Latam Airlines downgraded to Sell from Hold at Deutsche Bank
05/26/20 Raymond James
Latam Airlines downgraded to Underperform from Outperform at Raymond James
05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
AZUL Azul
$8.14 /

-0.26 (-3.10%)

05/28/20 BofA
Azul reinstated with a Neutral at BofA
05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
04/24/20 Morgan Stanley
Azul downgraded to Equal Weight from Overweight at Morgan Stanley
03/17/20 Deutsche Bank
Azul downgraded to Hold from Buy at Deutsche Bank
GOL Gol Linhas
$4.50 /

-0.2 (-4.26%)

05/28/20 BofA
Gol Linhas reinstated with a Neutral at BofA
04/24/20 Morgan Stanley
Gol Linhas downgraded to Equal Weight from Overweight at Morgan Stanley
04/08/20 Goldman Sachs
Gol Linhas downgraded to Neutral from Buy at Goldman Sachs
03/17/20 Deutsche Bank
Gol Linhas downgraded to Hold from Buy at Deutsche Bank
GOL Gol Linhas
$4.50 /

-0.2 (-4.26%)

LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

AZUL Azul
$8.14 /

-0.26 (-3.10%)

LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

LTM Latam Airlines
$1.12 /

-0.13 (-10.44%)

Recommendations
Ulta Beauty price target raised to $270 from $240 at Oppenheimer » 07:27
05/29/20
05/29
07:27
05/29/20
07:27
ULTA

Ulta Beauty

$243.36 /

-8.48 (-3.37%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

06:29 Today Wells Fargo
Ulta Beauty price target raised to $300 from $250 at Wells Fargo
05/12/20 Cleveland Research
Ulta Beauty lost share to Target and Sephoria, says Cleveland Research
05/11/20 Nomura Instinet
Ulta Beauty price target raised to $220 from $190 at Nomura Instinet
05/01/20 JPMorgan
Ulta Beauty, BJ's best near-term picks in retail, says JPMorgan
ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

ULTA Ulta Beauty
$243.36 /

-8.48 (-3.37%)

Recommendations
Okta price target raised to $185 from $130 at Oppenheimer » 07:26
05/29/20
05/29
07:26
05/29/20
07:26
OKTA

Okta

$183.99 /

+4.48 (+2.50%)

Oppenheimer analyst Shaul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$183.99 /

+4.48 (+2.50%)

OKTA Okta
$183.99 /

+4.48 (+2.50%)

06:45 Today Mizuho
Okta price target raised to $178 from $165 at Mizuho
06:43 Today Morgan Stanley
Okta price target raised to $173 from $131 at Morgan Stanley
06:02 Today Piper Sandler
Okta price target raised to $190 from $145 at Piper Sandler
05/26/20 Cowen
Okta price target raised to $195 from $150 at Cowen
OKTA Okta
$183.99 /

+4.48 (+2.50%)

OKTA Okta
$183.99 /

+4.48 (+2.50%)

OKTA Okta
$183.99 /

+4.48 (+2.50%)

OKTA Okta
$183.99 /

+4.48 (+2.50%)

Downgrade
Trimble downgraded to Hold from Buy at Craig-Hallum » 07:25
05/29/20
05/29
07:25
05/29/20
07:25
TRMB

Trimble

$41.99 /

-0.58 (-1.36%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRMB Trimble
$41.99 /

-0.58 (-1.36%)

TRMB Trimble
$41.99 /

-0.58 (-1.36%)

07:21 Today Craig-Hallum
Trimble downgraded to Hold from Buy at Craig-Hallum
03/24/20 Needham
Trimble price target lowered to $34 from $48 at Needham
01/09/20 KeyBanc
Trimble initiated with a Sector Weight at KeyBanc
07/10/19 JPMorgan
Trimble downgraded to Neutral from Overweight at JPMorgan
TRMB Trimble
$41.99 /

-0.58 (-1.36%)

Hot Stocks
Quest Diagnostics, Home State Health partner on COVID-19 testing » 07:25
05/29/20
05/29
07:25
05/29/20
07:25
DGX

Quest Diagnostics

$118.10 /

+2.55 (+2.21%)

Home State Health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
04/28/20
Fly Intel: Top five analyst upgrades
04/28/20 Morgan Stanley
Morgan Stanley upgrades Quest Diagnostics to Overweight on COVID testing boost
04/28/20 Morgan Stanley
Quest Diagnostics upgraded to Overweight from Equal Weight at Morgan Stanley
DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

DGX Quest Diagnostics
$118.10 /

+2.55 (+2.21%)

Downgrade
VF Corp. downgraded to Hold from Buy at Argus » 07:23
05/29/20
05/29
07:23
05/29/20
07:23
VFC

VF Corp.

$58.84 /

-3.33 (-5.36%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

07:15 Today Argus
VF Corp. downgraded to Hold from Buy at Argus
05/18/20 Susquehanna
VF Corp. price target lowered to $60 from $66 at Susquehanna
05/18/20 Credit Suisse
VF Corp. price target lowered to $60 from $70 at Credit Suisse
04/28/20 BTIG
VF Corp. initiated with a Neutral at BTIG
VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

VFC VF Corp.
$58.84 /

-3.33 (-5.36%)

Hot Stocks
Rexford Industrial acquires industrial property for $14.5M » 07:23
05/29/20
05/29
07:23
05/29/20
07:23
REXR

Rexford Industrial

$40.09 /

+0.59 (+1.49%)

Rexford Industrial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REXR Rexford Industrial
$40.09 /

+0.59 (+1.49%)

REXR Rexford Industrial
$40.09 /

+0.59 (+1.49%)

05/04/20 Capital One
Rexford Industrial downgraded to Equalweight from Overweight at Capital One
05/04/20 Capital One
Rexford Industrial downgraded to Equalweight from Overweight at Capital One
02/12/20 Stifel
Rexford has best lease dynamics among industrial REITs, says Stifel
08/07/19 Jefferies
Jefferies goes to Overweight from Underweight on smid-cap real estate sector
REXR Rexford Industrial
$40.09 /

+0.59 (+1.49%)

Downgrade
Straumann downgraded to Underweight from Overweight at Morgan Stanley » 07:23
05/29/20
05/29
07:23
05/29/20
07:23
SAUHY

Straumann

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAUHY Straumann
$0.00 /

+ (+0.00%)

05:41 Today Morgan Stanley
Straumann downgraded to Underweight from Overweight at Morgan Stanley
05/21/20 Deutsche Bank
Straumann price target lowered to CHF 860 from CHF 890 at Deutsche Bank
05/15/20 JPMorgan
Straumann downgraded to Underweight from Neutral at JPMorgan
05/06/20 Kepler Cheuvreux
Straumann downgraded to Hold from Buy at Kepler Cheuvreux
Hot Stocks
Former Twitter CEO Dick Costolo attacks Facebook after Fox News interview » 07:23
05/29/20
05/29
07:23
05/29/20
07:23
TWTR

Twitter

$31.60 /

-1.46 (-4.42%)

, FB

Facebook

$225.14 /

-4.03 (-1.76%)

Former Twitter (TWTR) CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
FB Facebook
$225.14 /

-4.03 (-1.76%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
05/21/20 Stifel
Facebook price target raised to $260 from $245 at Stifel
05/20/20 Deutsche Bank
Facebook Shops could be $30B revenue opportunity, says Deutsche Bank
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

FB Facebook
$225.14 /

-4.03 (-1.76%)

Downgrade
Trimble downgraded to Hold from Buy at Craig-Hallum » 07:21
05/29/20
05/29
07:21
05/29/20
07:21
TRMB

Trimble

$41.99 /

-0.58 (-1.36%)

Craig-Hallum downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRMB Trimble
$41.99 /

-0.58 (-1.36%)

TRMB Trimble
$41.99 /

-0.58 (-1.36%)

03/24/20 Needham
Trimble price target lowered to $34 from $48 at Needham
01/09/20 KeyBanc
Trimble initiated with a Sector Weight at KeyBanc
07/10/19 JPMorgan
Trimble downgraded to Neutral from Overweight at JPMorgan
TRMB Trimble
$41.99 /

-0.58 (-1.36%)

Hot Stocks
Akari Therapeutics says ongoing trials disrupted due to coronavirus spread » 07:21
05/29/20
05/29
07:21
05/29/20
07:21
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Downgrade
Continental AG downgraded to Equal Weight from Overweight at Morgan Stanley » 07:21
05/29/20
05/29
07:21
05/29/20
07:21
CTTAY

Continental AG

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTTAY Continental AG
$0.00 /

+ (+0.00%)

05/19/20 UBS
Continental AG price target raised to EUR 70 from EUR 62 at UBS
04/03/20 Pareto
Continental AG upgraded to Buy from Hold at Pareto
03/26/20 Morgan Stanley
Continental AG price target lowered to EUR 100 from EUR 120 at Morgan Stanley
03/25/20 Jefferies
Continental AG upgraded to Buy from Hold at Jefferies
Upgrade
Valeo upgraded to Overweight from Equal Weight at Morgan Stanley » 07:20
05/29/20
05/29
07:20
05/29/20
07:20
VLEEY

Valeo

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLEEY Valeo
$0.00 /

+ (+0.00%)

05/11/20 Citi
Citi opens '90-day Negative Catalyst ' on Valeo
05/07/20 Kepler Cheuvreux
Valeo downgraded to Reduce from Hold at Kepler Cheuvreux
04/01/20 Barclays
Valeo downgraded to Equal Weight from Overweight at Barclays
03/30/20 Exane BNP Paribas
Valeo upgraded to Neutral from Underperform at Exane BNP Paribas
Hot Stocks
Canopy Growth down 14% to $18.67 after reporting Q4 results  07:20
05/29/20
05/29
07:20
05/29/20
07:20
CGC

Canopy Growth

$22.13 /

+2.26 (+11.37%)

 
ShowHide Related Items >><<
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

CGC Canopy Growth
$22.13 /

+2.26 (+11.37%)

Hot Stocks
Akari Therapeutics pursuing clinical study opportunities in COVID-19 pneumonia » 07:19
05/29/20
05/29
07:19
05/29/20
07:19
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

The Company believes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Hot Stocks
CannTrust: Health Canada says licenses for Fenwick facility reinstated » 07:18
05/29/20
05/29
07:18
05/29/20
07:18
CTST

CannTrust

$0.64 /

+ (+0.00%)

CannTrust announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTST CannTrust
$0.64 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

07/12/19
CannTrust downgraded to Sell from Neutral at Eight Capital
07/09/19 Roth Capital
CannTrust downgraded to Neutral from Buy at Roth Capital
07/08/19
CannTrust downgraded to Neutral from Buy at Eight Capital
07/08/19 BofA/Merrill
BofA double downgrades CannTrust to Underperform after Health Canada probe
CTST CannTrust
$0.64 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

Hot Stocks
Twitter 'doing nothing' on China propaganda, 'will be regulated,' Trump tweets » 07:18
05/29/20
05/29
07:18
05/29/20
07:18
TWTR

Twitter

$31.60 /

-1.46 (-4.42%)

President Donald Trump…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
05/01/20
Fly Intel: Top five analyst downgrades
05/01/20 Deutsche Bank
Twitter price target raised to $28 from $22 at Deutsche Bank
TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

TWTR Twitter
$31.60 /

-1.46 (-4.42%)

Hot Stocks
Akari Therapeutics expects interim update on Phase I/II trial in AKC in mid-2020 » 07:17
05/29/20
05/29
07:17
05/29/20
07:17
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

The Company completed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Hot Stocks
Aveo Pharmaceuticals DEDUCTIVE trial advances to Phase 2 portion » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
AVEO

Aveo Pharmaceuticals

$9.22 /

+0.47 (+5.37%)

, AZN

AstraZeneca

$53.50 /

+1.04 (+1.98%)

Aveo (AVEO) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

05/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $10 from $6 at H.C. Wainwright
04/01/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $6 from $4 at H.C. Wainwright
03/31/20 Piper Sandler
Aveo Pharmaceuticals price target lowered to $18.50 from $20 at Piper Sandler
03/18/20 H.C. Wainwright
Aveo Pharmaceuticals price target raised to $4 from $1.75 at H.C. Wainwright
AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
05/04/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca
05/01/20 Guggenheim
AstraZeneca price target raised to 9,100 GBp from 8,900 GBp at Guggenheim
AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AVEO Aveo Pharmaceuticals
$9.22 /

+0.47 (+5.37%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

Hot Stocks
Akari Therapeutics sees site initiations delayed for Phase III trial in HSCT-TMA » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

During Q1 2020, Akari…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Upgrade
Hella KGaA Hueck upgraded to Equal Weight from Underweight at Morgan Stanley » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
HLLGY

Hella KGaA Hueck

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLLGY Hella KGaA Hueck
$0.00 /

+ (+0.00%)

05/27/20 JPMorgan
Hella KGaA Hueck price target raised to EUR 35 from EUR 32 at JPMorgan
05/27/20 Kepler Cheuvreux
Hella KGaA Hueck downgraded to Reduce from Buy at Kepler Cheuvreux
03/26/20 Kepler Cheuvreux
Hella KGaA Hueck upgraded to Buy from Hold at Kepler Cheuvreux
03/25/20 Jefferies
Hella KGaA Hueck upgraded to Buy from Hold at Jefferies
Recommendations
Zscaler price target raised to $100 from $80 at Wedbush » 07:16
05/29/20
05/29
07:16
05/29/20
07:16
ZS

Zscaler

$75.88 /

+1.34 (+1.80%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

06:32 Today Credit Suisse
Zscaler price target raised to $90 from $75 at Credit Suisse
06:14 Today Citi
Zscaler price target raised to $86 from $49 at Citi
06:03 Today Piper Sandler
Zscaler price target raised to $75 from $55 at Piper Sandler
05/26/20 Cowen
Zscaler price target raised to $80 from $70 at Cowen
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

Hot Stocks
Akari Therapeutics expects to meet with FDA, EMA on nomacopan for BP in Q3 » 07:15
05/29/20
05/29
07:15
05/29/20
07:15
AKTX

Akari Therapeutics

$2.00 /

-0.01 (-0.50%)

In May 2020, Akari…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

AKTX Akari Therapeutics
$2.00 /

-0.01 (-0.50%)

Upgrade
Polaris upgraded to Outperform at Wedbush as state reopening play » 07:15
05/29/20
05/29
07:15
05/29/20
07:15
PII

Polaris

$89.00 /

-1.885 (-2.07%)

Wedbush analyst James…

Wedbush analyst James Hardiman upgraded Polaris to Outperform from Neutral with a price target of $106, up from $68. The stock closed Thursday down $2.06 to $88.83. The powersports names in general, and Polaris in particular, could prove to be "great" ways to play the reopening of states, Hardiman tells investors in a research note. Consumers have been cooped up in their homes for months will take to the outdoors, while still being conscious of the ongoing risks associated with travel and large crowds, says the analyst. Even though Polaris shares have doubled off their bottom, the 13% year-to-date decline suggests that investors have yet to "fully digest this new bull case," contends Hardiman, who believes such a realization should push the shares past their pre-COVID highs.

ShowHide Related Items >><<
PII Polaris
$89.00 /

-1.885 (-2.07%)

PII Polaris
$89.00 /

-1.885 (-2.07%)

06:32 Today Wedbush
Polaris Industries upgraded to Outperform from Neutral at Wedbush
05/28/20 Raymond James
Polaris Industries price target raised to $108 from $81 at Raymond James
05/18/20 UBS
Polaris Industries price target lowered to $86 from $114 at UBS
04/30/20 KeyBanc
Polaris Industries price target raised to $90 from $70 at KeyBanc
PII Polaris
$89.00 /

-1.885 (-2.07%)

Downgrade
BRP Inc. downgraded to Sector Perform from Outperform at RBC Capital » 07:15
05/29/20
05/29
07:15
05/29/20
07:15
DOOO

BRP Inc.

$35.39 /

-1.66 (-4.48%)

RBC Capital analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOOO BRP Inc.
$35.39 /

-1.66 (-4.48%)

DOOO BRP Inc.
$35.39 /

-1.66 (-4.48%)

05:36 Today RBC Capital
BRP Inc. downgraded to Sector Perform from Outperform at RBC Capital
05/22/20 RBC Capital
BRP Inc. price target raised to C$46 from C$40 at RBC Capital
05/22/20 TD Securities
BRP Inc. price target raised to C$49 from C$30 at TD Securities
05/12/20 National Bank
National Bank downgrades BRP after 118% rebound off lows

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.